Advertisement

Rauschdrogen pp 229-313 | Cite as

Stimulanzien

  • Thomas Geschwinde

Zusammenfassung

Die Zusammenfassung verschiedener Wirkstoffe unter diesem, von lat. stimulus = Stachel, Antrieb, Reiz, abgeleiteten Begriff stellt auf die charakteristische anregende und leistungssteigernde Wirkungskomponente dieser Gruppe von Rauschdrogen ab. Synonym wird der ältere, heute weniger gebräuchliche Begriff „Excitantia“ verwendet.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bachmann P (1976) Das hyperkinetische Syndrom im Kindesalter. Huber, Bern Baumgartner WA, Black CT, Jones PF, Bland WH (1982) Radioimmunassay of cocaine in hair, concise communication. J Nucl Med 23: 790–792Google Scholar
  2. Beil H, Trojan A (1974) Zur Problematik des Amphetaminil (AN 1)-Mißbrauchs, MMW 116/48: 2121–2123Google Scholar
  3. Bejerot N (1970) A comparison of the effects of cocaine and synthetic central stimulants. Br J Addict 65: 35–37CrossRefGoogle Scholar
  4. Bell DS (1965) Comparison of amphetamine psychosis and schizophrenia. Br J Psychiatry 111: 701— 707Google Scholar
  5. Bell DS (1973) The experimental reproduction of amphetamine psychosis. Arch Gen Psychiatry 29: 34–40CrossRefGoogle Scholar
  6. Benchimol A, Bartrall H, Dresser KB (1978) Accelerated ventricular rhythm and cocaine abuse. Ann. Intern Med 88: 519–521Google Scholar
  7. Bettinger J (1980) Cocain intoxication, massive oral overdose. Ann Emerg Med 10: 429–433CrossRefGoogle Scholar
  8. Blejer-Prieto H (1965) Coca leaf and cocaine addiction — some historical notes. Can Med Assoc J 93: 700–704Google Scholar
  9. Bruns 0 (1941) Pervitin — Pharmakologie and Klinik. Fortschr Ther 17:37–44, 90–100Google Scholar
  10. Bundeskriminalamt (Hrsg) (1981) Kokain-Informationsschrift. WiesbadenGoogle Scholar
  11. Caldwell J et al. (1974) The biochemical pharmacology of abused drugs. I. Amphetamine, cocaine and LSD. Clin Pharmacol Ther 16: 625–633Google Scholar
  12. Chambers CD, Taylor WJR, Moffett AD (1972) The incidence of cocaine abuse among methadone maintenance patients. Int J Addict 7: 427–441Google Scholar
  13. Cleckner Pi (1976) Blowing some lines: Intracultural variation among Miami cocaine users. J Psychedelic Drugs 8: 37–42CrossRefGoogle Scholar
  14. Cohen H (1972) The amphetamine manifesto. Olympia Press, New YorkGoogle Scholar
  15. Cohen SV (1976) Influence of cocaine on sexuality. Med Aspects Hum Sex 10: 149–152Google Scholar
  16. Colpaert FC et al. (1978) Neuroleptic interference with the cocaine cue: Internal stimulus control of behavior and psychosis. Psychopharmacology (Berlin) 58: 257CrossRefGoogle Scholar
  17. Connell PH (1958) Amphetamine psychosis. Chapman, and Hall, LondonGoogle Scholar
  18. Cooper H, Ellinwood EH (1981) Cocain and Cocainismus. Dtsch Ärztebl. 19: 173–179Google Scholar
  19. Crowley A (1973) Cocaine. Level, San FranciscoGoogle Scholar
  20. Daube H (1942) Pervitinpsychosen. Nervenarzt 15: 20–25Google Scholar
  21. Dyke C van, Jatlow P, Ungerer J, Barash PG (1978) Oral cocaine: Plasma concentrations and central effects. Science 200: 211–213CrossRefGoogle Scholar
  22. Dyke C van et al. (1979) Cocaine and lidocaine have similar psychological effects after intranasal application. Life Sci 24: 271–274CrossRefGoogle Scholar
  23. Ellinwood EH Jr, Kilbey MM (eds) (1977) Cocaine and other stimulants. Plenum, New York Epstein PN et al. (1978) Changes in effects of cocaine during chronic treatment. Res Commun Chem Pathol Pharmacol 22: 93–105Google Scholar
  24. Fleurentin J, Pelt J-M (1982) Repertory of drugs and medicinal plants of Yemen. J Ethnopharmacol 6: 85 —108Google Scholar
  25. Fodor G (1965) New methods and recent developments of ephedrine, pyrrolizidine, granatane and tropane alkaloids. Recent Dev Chem Nat Carbon Compounds 1: 15–20Google Scholar
  26. Galambos E, Pfeifer AK, György L, Molnar D (1967) Study of the excitation induced by amphetamine, cocaine and alpha-methyltryptamine. Psychopharmacologia 11: 122–129CrossRefGoogle Scholar
  27. Gay GR, Sheppard CW, Inaba DS, Newmeyer JA (1973 a) Cocaine in perspective: „Gift from the Sun God“ to „The Rich Man’s Drug”. Drug Forum 2: 409–430Google Scholar
  28. Gay GR, Sheppard CW, Inaba DS, Newmeyer JA (1973 b) An old girl: Flyin’ slow, dyin’ slow, blindes by snow: Cocaine in perspective. Int J Addict 8: 1027–1042Google Scholar
  29. Gorodetzky CW (1970) Marihuana, LSD, Amphetamines. Drug Depend 5: 61–66Google Scholar
  30. Grasshof H (1962) Zusammenhänge zwischen Konstitution and Wirksamkeit bei Lokalanaesthetica. Fortschr. Arzneimittelforsch 4: 353–357Google Scholar
  31. Grinspoon L, Bakalar JB (1977) A kick from cocaine. A review of research on the drugs’s effects physical, social, and psychosocial. Psychol Today 3: 41–42, 78Google Scholar
  32. Gundlach H, Metraux A (1979) Freud, Kokain, Koller und Schleich. Psyche 33: 434–451Google Scholar
  33. Halbach H (1981) Amphetamine. Dtsch Ärztebi 78/50: 2398–2402Google Scholar
  34. Hanna JM (1974) Coca leaf use in southern Peru: Some biosocial aspects. Am Anthropol 76: 281–296CrossRefGoogle Scholar
  35. Hanna JM, Hornick CA (1977) Use of coca leaf in southern Peru: adaption or addiction. Bull Narc 29: 63–74Google Scholar
  36. Hasse HE, Schönhofer PS, Waldmann H (1973) Die Bedeutung weckaminartiger Substanzen in der Psychodynamik des Drogenkonsums bei Jugendlichen. Dtsch med Wochenschr 98: 295–301CrossRefGoogle Scholar
  37. Hirsch C (1928) Die Stellung des Kokains in der Lokalanästhesie einst und jetzt. Schmerz 1: 105–113Google Scholar
  38. Hollister LE, Gillespie HK (1970) Marihuana, ethanol and dextroamphetamine — mood and mental function alteration. Arch Gen Psychiatry 23: 199–204CrossRefGoogle Scholar
  39. Iffland R (1982) Fenetyllin-und Amphetaminspiegel im Urin nach Einnahme von Captagon. Arch Kriminol 169: 81–88Google Scholar
  40. Jain NC, Chinn DM, Sneath TC, Budd RD (1977) Simultaneous gas chromatographic determination of cocaine, methadone, methaqualone, phencyclidine, and propoxyphene. J Anal Toxicol 1: 192–194Google Scholar
  41. Javaid JI, Fischman MW, Schuster CR et al. (1978) Cocaine plasma concentration: Relation to physiological and subjective effects in humans. Science 202: 227–228CrossRefGoogle Scholar
  42. Jeri FR (1979) Further experience with the syndromes produces by coca paste. Bull Narc 15: 1–8Google Scholar
  43. Jeri FR, Sanchez C, Del Pozo T, Fernandez M (1978 a) The syndrome of coca paste. J Psychedelic Drugs 10:361— 370Google Scholar
  44. Jeri FR, Sanchez CC, Del Pozo T, Fenandez M (1978b) Further experience with the syndromes produced by coca paste smoking. Bull Narc 30: 1–11Google Scholar
  45. Jindal SP, Lutz T, Vestergaard P (1978) Mass spectrometris determination of cocaine and its biologically active metabolite, norcocaine, in human urine. Biomed Mass Spectrom 5: 658–663CrossRefGoogle Scholar
  46. Joachim H, Hochreuther J (1977) Untersuchungen über den Kombinationseffekt von Alkohol — Fenetyllin (Captagon) auf einige Reflexmechanismen des Menschen. Blutalkohol 14: 25–46Google Scholar
  47. Jordan SE, Lasslo A, Livingston HL, Alperin H (1958) Comparative pharmacology of cocaine and the diethylamide derivate of cocaine. Arch Int Pharmacodyn 4: 452–473Google Scholar
  48. Kalus F, Kucher J, Zutt J (1950) Über die psychotischen Bilder bei chronischem PervitinmiBbrauch. Psychiatr Neurol Med Psychol 2:109–116, 138–144Google Scholar
  49. Kellner E (1960) Preludinsucht und Preludinpsychose. Ther GGW 99: 524–530Google Scholar
  50. Kogan MJ, Vereby KG, Depace AC et al. (1977) Quantitative etermination of benzoylecgonine and cocaine in human biofluids by gas-liqiud chromatography. Anal Chem 49:1965 —1969Google Scholar
  51. Körner HH (1989) Doping: Der Drogenmißbrauch im Sport und im Stall. Rechtspolitik 11: 418–422Google Scholar
  52. Kramer E (1941) Die Pervitingefahr. MMW 16: 419–427Google Scholar
  53. Landewig D, Battegay R, Labhardt F (1969) Stimulantiensucht und -psychosen. Dtsch Med Wochenschr 94: 101–107CrossRefGoogle Scholar
  54. Lemmer B (1982) Benzodiazepine und Appetitzügler — Gebrauch und Mißbrauch. Med Monatsschr Pharm 4: 225–233Google Scholar
  55. Linck J (1987) Doping und staatliches Recht. NJW 41: 2545–2548Google Scholar
  56. Lundberg GD, Garriott JC, Reynolds PC, Cravey RH (1977) Cocaine-related death. J Forensic Sci 22: 402–408Google Scholar
  57. Martin RT (1970) The role of coca in the history, religion, and medicine of South American Indians. Econ Bot 24/4: 422–438Google Scholar
  58. Megges G (1983) Massive psychische Abhängigkeit…, Cocain — Cocaismus, Cocainismus. Kriminalistik 2: 62–69Google Scholar
  59. Megges G (1986) „Speed“ — Zur Suchtgefährlichkeit der Amphetamine. Kriminalistik 5: 224227Google Scholar
  60. Minister für Arbeit, Gesundheit und Soziales des Landes Nordrhein-Westfalen (Hrsg) (1981) Cocain heute, Dokumentation des IDIS. Verlag für Dokumentation und Information über Sozialmedizin und öffentliches Gesundheitswesen, BielefeldGoogle Scholar
  61. Mortimer WG (1974) History of coca: „The divine plant“ of the Incas. And/Or Press, San FranciscoGoogle Scholar
  62. Mule SJ (ed) (1976) Cocaine: Chemical, biological, clinical, social and treatment aspects. CRC Press, Cleveland/OHGoogle Scholar
  63. Murphy HBM, Rios O, Negrete JC (1969) The effects of abstinence and of retraining on the chewer of coca leaf. Bull Narc 21: 41–47Google Scholar
  64. Nieforth KA (1971) Psychotomimetic phenethylamines. J Pharm Sci 60: 655–659CrossRefGoogle Scholar
  65. Nieschulz 0 (1969) Kokaismus und Kokainismus. MMW 44: 2276–2284Google Scholar
  66. Nieschulz O (1971) Psychopharmakologische Untersuchungen über Cocain und Ecgonin. Ein Beitrag zum Problem des Cocaismus und Cocainismus, Arzneimittelforsch 21: 275–284Google Scholar
  67. Nieschulz O, Schmersahl P (1969) Untersuchungen über die Bedeutung des Kalkzusatzes beim Kauen von Coca-Blättern. Planta Med 17: 178–183CrossRefGoogle Scholar
  68. Nobel H (1985) Teufelsdroge Nr. 2 auf dem Vormarsch — Kokain: Schmuggel, Preise, Anwendungsformen, Folgen. Kriminalistik 3: 130–149Google Scholar
  69. Panse F, Klages W (1964) Klinisch-psychopathologische Beobachtungen bei chronischem Mißbrauch von Ephedrin und verwandten Substanzen. Arch Psychiatr Nervenkr 206: 6995CrossRefGoogle Scholar
  70. Phillips J, Wynne RD (1980) Cocaine. Avon, New YorkGoogle Scholar
  71. Post RM (1975) Cocaine psychoses: A continuum model. Am J Psychiatry 132: 225–231Google Scholar
  72. Post RM, Kopanda RT (1976) Cocaine, kindling, and psychosis. Am J Psychiatry 133: 627–634Google Scholar
  73. Post RM, Kotin J, Goodwin FK (1974) The effects of cocaine on depressed patients. Am J Psychiatry 131: 511–517Google Scholar
  74. Prokop H (1968) Halluzinose bei Ephedrinsucht. Nervenarzt 39: 71–75Google Scholar
  75. Prokop H (1969) Über Fälle mit Ephedrin-und Preludinsucht. Wien Klin Wochenschr 81: 269— 271Google Scholar
  76. Rafla FK, Epstein RL (1979) Identification of cocaine and its metabolits in human urine in the presence of ethyl alcohol. J Anal Toxicol 3: 59–63Google Scholar
  77. Resnick RB, Kestenbaum RS, Schwarz LK (1976) Acute systemic effects of cocaine in man: A controlled study by intranasal and intravenous routes. Psychopharmacol Bull 12: 44–45Google Scholar
  78. Sano J, Nagasaka (1956) Über chronische Weckaminsucht in Japan. Fortschr Neurol Psychiatr 24: 391–394Google Scholar
  79. Scheidt J vom (1973) Sigmund Freud und das Kokain. Psyche 27: 385–430Google Scholar
  80. Siegel RK (1978) Cocaine hallucinations. Am J Psychiatry 135: 309–314Google Scholar
  81. Smith DE, Wesson DR (1978) Cocaine. J Psychedelic Drugs 10: 351–360CrossRefGoogle Scholar
  82. Suarez CA, Arango A, Lester JL (1977) Cocaine — condom ingestion. Surgical treatment. JAMA 238: 1391–1392CrossRefGoogle Scholar
  83. Suzuki O, Hattori H, Asano M (1984) Nails and hair as useful materials for detection of methamphetamin or amphetamin abuse. Forensic Sci Intern 24: 9–16CrossRefGoogle Scholar
  84. Täschner K-L (1988) Koka und Kokain — Konsum und Wirkungen. Deutscher Ärzteverlag, KölnGoogle Scholar
  85. Täschner K-L (1989) Cocain — Kein „Schnee“ von gestern. Dtsch Apoth Z 37: 1955–1959Google Scholar
  86. Täschner K-L, Richtberg W (1982) Kokain-Report. Akademische Verlagsgesellschaft, WiesbadenGoogle Scholar
  87. Thamm BG (1984) Kokain — Schnee von Morgen. Psychol heute 11: 56–59Google Scholar
  88. Thamm BG (1986) Andenschnee: die lange Linie des Kokains. Sphinx, BaselGoogle Scholar
  89. Villinger W (1941) Pervitin, Suchtproblem und Suchtbekämpfung. Nervenarzt 14: 405–408Google Scholar
  90. Voigt HP (1982) Zum Thema: Kokain. Sphinx, BaselGoogle Scholar
  91. Wetli CV, Wright RK (1969) Death caused by recreational cocaine use. JAMA 241: 2519–2522CrossRefGoogle Scholar
  92. Wilkinson P, Dyke C van, Jatlow P et al. (1980) Intranasal and oral cocaine kinetics. Clin Pharmacol Ther 27: 386–394CrossRefGoogle Scholar
  93. Witkop B, Foltz CM (1957) Studies on the stereochemistry of ephedrine and yr-ephedrine. J Chem Soc 79: 197–199CrossRefGoogle Scholar
  94. Zapata-Ortiz V, Castro de la Mata R, Barrantes-Campos R (1961) Die anticonvulsive Wirkung des Cocains. Arzneimittelforsch 11: 657–662Google Scholar
  95. Zuckerman B, Frank DA, Hingson R et al. (1989) Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 320: 762–768CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • Thomas Geschwinde
    • 1
  1. 1.HanauDeutschland

Personalised recommendations